Brief: Cerevel Therapeutics Posts Q4 Net Loss $92.808 Million
22/02/2023 11:35
Feb 22 (Reuters) - Cerevel Therapeutics Q4 net income USD -92.808 million. * Q4 operating expenses USD 107.247 million
Recent news on Cerevel Therapeutics Holdings
See all newsBrief: Abbvie Reaffirms FY Adj Diluted EPS Guidance Range $10.71-$10.91
Cerevel Therapeutics Holdings Inc expected to post a loss of 61 cents a share - Earnings Preview
Cerevel Therapeutics Holdings Inc expected to post a loss of 62 cents a share - Earnings Preview
Cerevel Therapeutics Holdings Inc expected to post a loss of 61 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Ally Financial, Zscaler, Las Vegas Sands